News Home

Will BridgeBio Pharma Inc (BBIO) Stay at the Top of the Healthcare Sector?

Tuesday, September 26, 2023 11:57 AM | InvestorsObserver Analysts

Mentioned in this article

Will BridgeBio Pharma Inc (BBIO) Stay at the Top of the Healthcare Sector?

BridgeBio Pharma Inc (BBIO) is near the top in its sector according to InvestorsObserver. BBIO gets an overall rating of 73. That means it scores higher than 73% of stocks. BridgeBio Pharma Inc gets a 94 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Overall Score - 73
BBIO has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on BBIO!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With BridgeBio Pharma Inc Stock Today?

BridgeBio Pharma Inc (BBIO) stock has gained 2.33% while the S&P 500 is lower by -1.18% as of 11:51 AM on Tuesday, Sep 26. BBIO has risen $0.63 from the previous closing price of $27.08 on volume of 418,554 shares. Over the past year the S&P 500 is higher by 17.27% while BBIO has risen 203.50%. BBIO lost -$3.75 per share the over the last 12 months. Click Here to get the full Stock Report for BridgeBio Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App